img

Global Nucleic Acid-Based Multiplex Assays Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nucleic Acid-Based Multiplex Assays Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others. 
Nucleic Acid-Based Multiplex Assays report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nucleic Acid-Based Multiplex Assays market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Companion Diagnostics and Research & Development are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nucleic Acid-Based Multiplex Assays industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nucleic Acid-Based Multiplex Assays key companies include Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Lab, QIAGEN, BD, Abcam, Seegene and Meso Scale Diagnostics, etc. Luminex, Thermo Fisher Scientific, Illumina are top 3 players and held % share in total in 2022.
Nucleic Acid-Based Multiplex Assays can be divided into Reagents & Consumables, Instruments & Accessories and Software & Services,, etc. Reagents & Consumables is the mainstream product in the market, accounting for % share globally in 2022.
Nucleic Acid-Based Multiplex Assays is widely used in various fields, such as Companion Diagnostics, Research & Development and Clinical Diagnostics,, etc. Companion Diagnostics provides greatest supports to the Nucleic Acid-Based Multiplex Assays industry development. In 2022, global % share of Nucleic Acid-Based Multiplex Assays went into Companion Diagnostics filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nucleic Acid-Based Multiplex Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories
Segment by Type
Reagents & Consumables
Instruments & Accessories
Software & Services

Segment by Application


Companion Diagnostics
Research & Development
Clinical Diagnostics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nucleic Acid-Based Multiplex Assays market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Nucleic Acid-Based Multiplex Assays introduction, etc. Nucleic Acid-Based Multiplex Assays Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Nucleic Acid-Based Multiplex Assays market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Nucleic Acid-Based Multiplex Assays
1.1 Nucleic Acid-Based Multiplex Assays Market Overview
1.1.1 Nucleic Acid-Based Multiplex Assays Product Scope
1.1.2 Nucleic Acid-Based Multiplex Assays Market Status and Outlook
1.2 Global Nucleic Acid-Based Multiplex Assays Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Nucleic Acid-Based Multiplex Assays Market Size by Region (2024-2034)
1.4 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Region (2024-2024)
1.5 Global Nucleic Acid-Based Multiplex Assays Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Nucleic Acid-Based Multiplex Assays Market Size (2024-2034)
1.6.1 North America Nucleic Acid-Based Multiplex Assays Market Size (2024-2034)
1.6.2 Europe Nucleic Acid-Based Multiplex Assays Market Size (2024-2034)
1.6.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size (2024-2034)
1.6.4 Latin America Nucleic Acid-Based Multiplex Assays Market Size (2024-2034)
1.6.5 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size (2024-2034)
2 Nucleic Acid-Based Multiplex Assays Market by Type
2.1 Introduction
2.1.1 Reagents & Consumables
2.1.2 Instruments & Accessories
2.1.3 Software & Services
2.2 Global Nucleic Acid-Based Multiplex Assays Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Type (2024-2024)
2.2.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Nucleic Acid-Based Multiplex Assays Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Nucleic Acid-Based Multiplex Assays Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Nucleic Acid-Based Multiplex Assays Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Nucleic Acid-Based Multiplex Assays Revenue Breakdown by Type (2024-2034)
3 Nucleic Acid-Based Multiplex Assays Market Overview by Application
3.1 Introduction
3.1.1 Companion Diagnostics
3.1.2 Research & Development
3.1.3 Clinical Diagnostics
3.2 Global Nucleic Acid-Based Multiplex Assays Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Application (2024-2024)
3.2.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Nucleic Acid-Based Multiplex Assays Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Nucleic Acid-Based Multiplex Assays Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Nucleic Acid-Based Multiplex Assays Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Nucleic Acid-Based Multiplex Assays Revenue Breakdown by Application (2024-2034)
4 Nucleic Acid-Based Multiplex Assays Competition Analysis by Players
4.1 Global Nucleic Acid-Based Multiplex Assays Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nucleic Acid-Based Multiplex Assays as of 2022)
4.3 Date of Key Players Enter into Nucleic Acid-Based Multiplex Assays Market
4.4 Global Top Players Nucleic Acid-Based Multiplex Assays Headquarters and Area Served
4.5 Key Players Nucleic Acid-Based Multiplex Assays Product Solution and Service
4.6 Competitive Status
4.6.1 Nucleic Acid-Based Multiplex Assays Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Luminex
5.1.1 Luminex Profile
5.1.2 Luminex Main Business
5.1.3 Luminex Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
5.1.4 Luminex Nucleic Acid-Based Multiplex Assays Revenue (US$ Million) & (2024-2024)
5.1.5 Luminex Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Revenue (US$ Million) & (2024-2024)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Illumina
5.3.1 Illumina Profile
5.3.2 Illumina Main Business
5.3.3 Illumina Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
5.3.4 Illumina Nucleic Acid-Based Multiplex Assays Revenue (US$ Million) & (2024-2024)
5.3.5 Bio-Rad Lab Recent Developments
5.4 Bio-Rad Lab
5.4.1 Bio-Rad Lab Profile
5.4.2 Bio-Rad Lab Main Business
5.4.3 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
5.4.4 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Revenue (US$ Million) & (2024-2024)
5.4.5 Bio-Rad Lab Recent Developments
5.5 QIAGEN
5.5.1 QIAGEN Profile
5.5.2 QIAGEN Main Business
5.5.3 QIAGEN Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
5.5.4 QIAGEN Nucleic Acid-Based Multiplex Assays Revenue (US$ Million) & (2024-2024)
5.5.5 QIAGEN Recent Developments
5.6 BD
5.6.1 BD Profile
5.6.2 BD Main Business
5.6.3 BD Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
5.6.4 BD Nucleic Acid-Based Multiplex Assays Revenue (US$ Million) & (2024-2024)
5.6.5 BD Recent Developments
5.7 Abcam
5.7.1 Abcam Profile
5.7.2 Abcam Main Business
5.7.3 Abcam Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
5.7.4 Abcam Nucleic Acid-Based Multiplex Assays Revenue (US$ Million) & (2024-2024)
5.7.5 Abcam Recent Developments
5.8 Seegene
5.8.1 Seegene Profile
5.8.2 Seegene Main Business
5.8.3 Seegene Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
5.8.4 Seegene Nucleic Acid-Based Multiplex Assays Revenue (US$ Million) & (2024-2024)
5.8.5 Seegene Recent Developments
5.9 Meso Scale Diagnostics
5.9.1 Meso Scale Diagnostics Profile
5.9.2 Meso Scale Diagnostics Main Business
5.9.3 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
5.9.4 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Revenue (US$ Million) & (2024-2024)
5.9.5 Meso Scale Diagnostics Recent Developments
5.10 Randox Laboratories
5.10.1 Randox Laboratories Profile
5.10.2 Randox Laboratories Main Business
5.10.3 Randox Laboratories Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
5.10.4 Randox Laboratories Nucleic Acid-Based Multiplex Assays Revenue (US$ Million) & (2024-2024)
5.10.5 Randox Laboratories Recent Developments
6 North America
6.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nucleic Acid-Based Multiplex Assays Market Dynamics
11.1 Nucleic Acid-Based Multiplex Assays Industry Trends
11.2 Nucleic Acid-Based Multiplex Assays Market Drivers
11.3 Nucleic Acid-Based Multiplex Assays Market Challenges
11.4 Nucleic Acid-Based Multiplex Assays Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Nucleic Acid-Based Multiplex Assays Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Nucleic Acid-Based Multiplex Assays Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Nucleic Acid-Based Multiplex Assays Market Size Share by Region (2024-2024)
Table 4. Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Nucleic Acid-Based Multiplex Assays Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Nucleic Acid-Based Multiplex Assays Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Type (2024-2024)
Table 9. Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Type (2024-2034)
Table 11. North America Nucleic Acid-Based Multiplex Assays Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Nucleic Acid-Based Multiplex Assays Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Nucleic Acid-Based Multiplex Assays Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Nucleic Acid-Based Multiplex Assays Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Nucleic Acid-Based Multiplex Assays Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Nucleic Acid-Based Multiplex Assays Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Nucleic Acid-Based Multiplex Assays Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Nucleic Acid-Based Multiplex Assays Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Nucleic Acid-Based Multiplex Assays Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Nucleic Acid-Based Multiplex Assays Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Nucleic Acid-Based Multiplex Assays Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Nucleic Acid-Based Multiplex Assays Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Application (2024-2024)
Table 24. Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Application (2024-2034)
Table 26. North America Nucleic Acid-Based Multiplex Assays Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Nucleic Acid-Based Multiplex Assays Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Nucleic Acid-Based Multiplex Assays Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Nucleic Acid-Based Multiplex Assays Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Nucleic Acid-Based Multiplex Assays Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Nucleic Acid-Based Multiplex Assays Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Nucleic Acid-Based Multiplex Assays Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Nucleic Acid-Based Multiplex Assays Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Nucleic Acid-Based Multiplex Assays Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Nucleic Acid-Based Multiplex Assays Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Nucleic Acid-Based Multiplex Assays Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nucleic Acid-Based Multiplex Assays as of 2022)
Table 39. Date of Key Players Enter into Nucleic Acid-Based Multiplex Assays Market
Table 40. Global Nucleic Acid-Based Multiplex Assays Key Players Headquarters and Area Served
Table 41. Nucleic Acid-Based Multiplex Assays Product Solution and Service
Table 42. Global Nucleic Acid-Based Multiplex Assays Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Luminex Basic Information List
Table 45. Luminex Description and Business Overview
Table 46. Luminex Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
Table 47. Revenue (US$ Million) in Nucleic Acid-Based Multiplex Assays Business of Luminex (2024-2024)
Table 48. Luminex Recent Developments
Table 49. Thermo Fisher Scientific Basic Information List
Table 50. Thermo Fisher Scientific Description and Business Overview
Table 51. Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
Table 52. Revenue (US$ Million) in Nucleic Acid-Based Multiplex Assays Business of Thermo Fisher Scientific (2024-2024)
Table 53. Thermo Fisher Scientific Recent Developments
Table 54. Illumina Basic Information List
Table 55. Illumina Description and Business Overview
Table 56. Illumina Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
Table 57. Revenue (US$ Million) in Nucleic Acid-Based Multiplex Assays Business of Illumina (2024-2024)
Table 58. Illumina Recent Developments
Table 59. Bio-Rad Lab Basic Information List
Table 60. Bio-Rad Lab Description and Business Overview
Table 61. Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
Table 62. Revenue (US$ Million) in Nucleic Acid-Based Multiplex Assays Business of Bio-Rad Lab (2024-2024)
Table 63. Bio-Rad Lab Recent Developments
Table 64. QIAGEN Basic Information List
Table 65. QIAGEN Description and Business Overview
Table 66. QIAGEN Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
Table 67. Revenue (US$ Million) in Nucleic Acid-Based Multiplex Assays Business of QIAGEN (2024-2024)
Table 68. QIAGEN Recent Developments
Table 69. BD Basic Information List
Table 70. BD Description and Business Overview
Table 71. BD Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
Table 72. Revenue (US$ Million) in Nucleic Acid-Based Multiplex Assays Business of BD (2024-2024)
Table 73. BD Recent Developments
Table 74. Abcam Basic Information List
Table 75. Abcam Description and Business Overview
Table 76. Abcam Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
Table 77. Revenue (US$ Million) in Nucleic Acid-Based Multiplex Assays Business of Abcam (2024-2024)
Table 78. Abcam Recent Developments
Table 79. Seegene Basic Information List
Table 80. Seegene Description and Business Overview
Table 81. Seegene Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
Table 82. Revenue (US$ Million) in Nucleic Acid-Based Multiplex Assays Business of Seegene (2024-2024)
Table 83. Seegene Recent Developments
Table 84. Meso Scale Diagnostics Basic Information List
Table 85. Meso Scale Diagnostics Description and Business Overview
Table 86. Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
Table 87. Revenue (US$ Million) in Nucleic Acid-Based Multiplex Assays Business of Meso Scale Diagnostics (2024-2024)
Table 88. Meso Scale Diagnostics Recent Developments
Table 89. Randox Laboratories Basic Information List
Table 90. Randox Laboratories Description and Business Overview
Table 91. Randox Laboratories Nucleic Acid-Based Multiplex Assays Products, Services and Solutions
Table 92. Revenue (US$ Million) in Nucleic Acid-Based Multiplex Assays Business of Randox Laboratories (2024-2024)
Table 93. Randox Laboratories Recent Developments
Table 94. North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2024) & (US$ Million)
Table 95. North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2034) & (US$ Million)
Table 96. Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2024) & (US$ Million)
Table 97. Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2034) & (US$ Million)
Table 98. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 99. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2024-2024) & (US$ Million)
Table 100. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2024-2034) & (US$ Million)
Table 101. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Share by Region (2024-2024)
Table 102. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Share by Region (2024-2034)
Table 103. Latin America Nucleic Acid-Based Multiplex Assays Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 104. Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2024) & (US$ Million)
Table 105. Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2034) & (US$ Million)
Table 106. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 107. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2024) & (US$ Million)
Table 108. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2024-2034) & (US$ Million)
Table 109. Nucleic Acid-Based Multiplex Assays Market Trends
Table 110. Nucleic Acid-Based Multiplex Assays Market Drivers
Table 111. Nucleic Acid-Based Multiplex Assays Market Challenges
Table 112. Nucleic Acid-Based Multiplex Assays Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid-Based Multiplex Assays Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Nucleic Acid-Based Multiplex Assays Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Nucleic Acid-Based Multiplex Assays Market Share by Regions: 2022 VS 2034
Figure 4. Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Nucleic Acid-Based Multiplex Assays Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Nucleic Acid-Based Multiplex Assays Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Nucleic Acid-Based Multiplex Assays Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Reagents & Consumables
Figure 11. Global Reagents & Consumables Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Instruments & Accessories
Figure 13. Global Instruments & Accessories Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Software & Services
Figure 15. Global Software & Services Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Nucleic Acid-Based Multiplex Assays Market Size Share by Type: 2022 & 2034
Figure 17. North America Nucleic Acid-Based Multiplex Assays Revenue Market Share by Type (2024-2034)
Figure 18. Europe Nucleic Acid-Based Multiplex Assays Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Nucleic Acid-Based Multiplex Assays Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Nucleic Acid-Based Multiplex Assays Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Nucleic Acid-Based Multiplex Assays Revenue Market Share by Type (2024-2034)
Figure 22. Companion Diagnostics Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Research & Development Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Clinical Diagnostics Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Nucleic Acid-Based Multiplex Assays Market Size Share by Application: 2022 & 2034
Figure 26. North America Nucleic Acid-Based Multiplex Assays Revenue Market Share by Application (2024-2034)
Figure 27. Europe Nucleic Acid-Based Multiplex Assays Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Nucleic Acid-Based Multiplex Assays Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Nucleic Acid-Based Multiplex Assays Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Nucleic Acid-Based Multiplex Assays Revenue Market Share by Application (2024-2034)
Figure 31. Nucleic Acid-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Nucleic Acid-Based Multiplex Assays Market Share in 2022
Figure 33. North America Nucleic Acid-Based Multiplex Assays Market Share by Country (2024-2034)
Figure 34. U.S. Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 37. France Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Share by Region (2024-2034)
Figure 43. China Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 47. India Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Nucleic Acid-Based Multiplex Assays Market Share by Country (2024-2034)
Figure 50. Mexico Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Share by Country (2024-2034)
Figure 53. Turkey Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Nucleic Acid-Based Multiplex Assays Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries